Indian firm seeks EUA in PH for its Covid-19 vaccine Covaxin
MANILA, Philippines — India-based firm Bharat Biotech has applied for emergency use authorization (EUA) for its Covid-19 vaccine Covaxin, the Food and Drug Administration (FDA) said Thursday.
“They submitted an application this morning and pre-evaluation is going on,” FDA Director-General Eric Domingo told INQUIRER.net in a text message.
Securing an EUA will allow a new vaccine to be administered in the country.
Other companies seeking EUA approval before the Philippine regulators are British firm AstraZeneca, Russian company Gamaleya Research Institute and Chinese drug maker Sinovac Biotech.
So far, only US pharmaceutical giant Pfizer has secured the FDA clearance for its vaccine’s use in the Philippines.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.